Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study

about

Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study

Item

http://www.wikidata.org/entity/Q57483689

description

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Effects of YuPingFeng granules ...... ized, placebo-controlled study

@en

Effects of YuPingFeng granules ...... ized, placebo-controlled study

@nl

type

Item

label

Effects of YuPingFeng granules ...... ized, placebo-controlled study

@en

Effects of YuPingFeng granules ...... ized, placebo-controlled study

@nl

prefLabel

Effects of YuPingFeng granules ...... ized, placebo-controlled study

@en

Effects of YuPingFeng granules ...... ized, placebo-controlled study

@nl

P1476

Effects of YuPingFeng granules ...... ized, placebo-controlled study

@en

P2093

Chunxue Bai

http://www.w3.org/2001/XMLSchema#string

Fenglei Li

http://www.w3.org/2001/XMLSchema#string

Haoyan Wang

http://www.w3.org/2001/XMLSchema#string

Jinfang Ma

http://www.w3.org/2001/XMLSchema#string

Jinping Zheng

http://www.w3.org/2001/XMLSchema#string

Juan Du

http://www.w3.org/2001/XMLSchema#string

Pingyan Chen

http://www.w3.org/2001/XMLSchema#string

Xin Li

http://www.w3.org/2001/XMLSchema#string

Yanwei Chen

http://www.w3.org/2001/XMLSchema#string

Zhe Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trial

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study.

Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.

Adjuvant Treatment with Yupingfeng Formula for Recurrent Respiratory Tract Infections in Children: A Meta-analysis of Randomized Controlled Trials.

Yupingfeng Pulvis Regulates the Balance of T Cell Subsets in Asthma Mice.

Anti-inflammatory effect of Yu-Ping-Feng-San via TGF-β1 signaling suppression in rat model of COPD.

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.

P304

3107-3114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S170555

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zhong Nanshan

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30323581

http://www.w3.org/2001/XMLSchema#string

P921

health policy

placebo

P932

6174891

http://www.w3.org/2001/XMLSchema#string